OXIDRIVE™ is a multi-compound research solution formulated to investigate mitochondrial efficiency, cellular energy metabolism, lipid oxidation signaling, and endurance-associated pathways. This research matrix combines several investigational compounds studied for their potential influence on metabolic regulation, circadian rhythm pathways, and mitochondrial activity.
GW-0742 has been explored in laboratory settings for its involvement in pathways related to fatty acid metabolism and endurance-associated gene expression. SR9009 has been studied for its interaction with nuclear receptors linked to circadian rhythm and metabolic signaling. SLU-PP-332 is currently being researched for its potential role in mitochondrial biogenesis and oxidative metabolism modulation. BAM15 has been examined for its effects on mitochondrial uncoupling processes in controlled research environments.
This combination allows researchers to explore multi-mechanism metabolic signaling and mitochondrial pathway interaction within a single standardized liquid preparation.
Contents per mL
• GW-0742 – 15 mg
• SR9009 – 15 mg
• SLU-PP-332 – 5 mg
• BAM15 – 500 mcg
Research Focus
• Mitochondrial activity pathways
• Cellular energy utilization
• Lipid oxidation signaling
• Circadian metabolic regulation
• Endurance-related cellular pathways
• Multi-pathway metabolic interaction research
Specifications
• Size: 30 mL
• Format: liquid research solution
• Standardized concentration per mL
Disclaimer
For laboratory research use only.
Not for human or veterinary use.
Not intended to diagnose, treat, cure, or prevent any disease.
